Ethiopia vs Paraguay: Average cost of multi drug-resistant tuberculosis treatment
Ethiopia
5,583 constant 2022 US$
in 2024
Paraguay
11,664 constant 2022 US$
in 2024
Ethiopia rank
7th
Paraguay rank
5th
Average cost of multi drug-resistant tuberculosis treatment over time
- Ethiopia
- Paraguay
How they compare
Paraguay currently reports 11,664 constant 2022 US$ against 5,583 constant 2022 US$ in Ethiopia, a difference of 6,081 constant 2022 US$.
That makes Paraguay's figure about 2.1 times Ethiopia's.
The two have swapped places 4 times across 6 shared years of data; in 2017 it was Paraguay ahead.
Ethiopia ranks 7th and Paraguay ranks 5th of 92 countries.
Ethiopia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ethiopia | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,815 constant 2022 US$ | 3,182 constant 2022 US$ | 633.5 constant 2022 US$ | Ethiopia |
| 2020s | 4,576 constant 2022 US$ | 4,347 constant 2022 US$ | 229 constant 2022 US$ | Ethiopia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Ethiopia or Paraguay?
- Paraguay, at 11,664 constant 2022 US$ against 5,583 constant 2022 US$ in Ethiopia as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Ethiopia and Paraguay?
- 6,081 constant 2022 US$, with Paraguay ahead.
- How many years of comparable data are there for Ethiopia and Paraguay?
- 6 years are reported by both, from 2017 to 2024.
- How do Ethiopia and Paraguay rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Ethiopia ranks 7th and Paraguay ranks 5th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.